Member Profile

A new biopharmaceutical company with a focus on integrated new drug R&D.
Sinew Pharma has six major products in two applications on hepatotoxicity-free acetaminophen (AAP) and fatty liver disease. The breakthrough hepatotoxicity-free AAP product (that produces minimal toxic metabolite) and an antidote for AAP overdose can help solve the long-standing problem caused by chronic and/or incidentally AAP overdose-induced acute liver failure or even death over the past years.
It is a new safe product that may effectively treat fatty liver disease or steatohepatitis, for which there is no standard treatment yet. In the pipeline, we also have new chemical entities and new combos at the stage of preclinical research.

Product Pipelines

Please move your mouse cursor over abbreviations with periods to see their full names.